Blood tests at the time of diagnoses of lung cancer may speed up treatment decisions
A study from Gundersen Health System, La Crosse, Wisconsin, reveals to the value of blood-based genomic and proteomic testing in patients with lung cancer at the time of initial diagnoses. Non-small cell lung cancer (NSCLC) ...
Oct 18, 2016
0
0